TrialBritish journal of cancer2008

Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial.

O Nehls et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.